Anatara Lifesciences Ltd (ANR.AX)
AUD 0.05
(0.0%)
AUD 0.05
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 | -982.1 Thousand AUD | -179.66% |
| 2023 | -351.18 Thousand AUD | 66.69% |
| 2022 | -1.05 Million AUD | 68.55% |
| 2021 | -3.35 Million AUD | -24.97% |
| 2020 | -2.68 Million AUD | -97.22% |
| 2019 | -1.36 Million AUD | 6.05% |
| 2018 | -1.44 Million AUD | 83.49% |
| 2017 | -8.76 Million AUD | -37.26% |
| 2016 | -6.38 Million AUD | -326.5% |
| 2015 | -1.49 Million AUD | 79.9% |
| 2014 | -7.45 Million AUD | -2761.37% |
| 2013 | 279.94 Thousand AUD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q4 | -982.1 Thousand AUD | 0.0% |
| 2024 FY | -932.01 Thousand AUD | -165.39% |
| 2024 Q2 | -1.03 Million AUD | 0.0% |
| 2023 Q4 | -351.18 Thousand AUD | 0.0% |
| 2023 FY | -351.18 Thousand AUD | 66.69% |
| 2023 Q2 | -1.29 Million AUD | 0.0% |
| 2022 Q4 | -1.05 Million AUD | 0.0% |
| 2022 Q2 | -2.48 Million AUD | 0.0% |
| 2022 FY | -1.05 Million AUD | 68.55% |
| 2021 Q2 | -3.67 Million AUD | 0.0% |
| 2021 Q4 | -3.35 Million AUD | 0.0% |
| 2021 FY | -3.35 Million AUD | -24.97% |
| 2020 Q2 | -3.79 Million AUD | 0.0% |
| 2020 FY | -2.68 Million AUD | -97.22% |
| 2020 Q4 | -2.68 Million AUD | 0.0% |
| 2019 FY | -1.36 Million AUD | 6.05% |
| 2019 Q4 | -1.36 Million AUD | 0.0% |
| 2019 Q2 | -1.49 Million AUD | 0.0% |
| 2018 Q2 | -2.44 Million AUD | 0.0% |
| 2018 FY | -1.44 Million AUD | 83.49% |
| 2018 Q4 | -1.44 Million AUD | 0.0% |
| 2017 Q2 | -5.91 Million AUD | 0.0% |
| 2017 Q4 | -8.76 Million AUD | 0.0% |
| 2017 FY | -8.76 Million AUD | -37.26% |
| 2016 FY | -6.38 Million AUD | -326.5% |
| 2016 Q2 | -3.48 Million AUD | 0.0% |
| 2016 Q4 | -6.38 Million AUD | 0.0% |
| 2015 Q2 | -2.47 Million AUD | 0.0% |
| 2015 FY | -1.49 Million AUD | 79.9% |
| 2015 Q4 | -1.49 Million AUD | 0.0% |
| 2014 FY | -7.45 Million AUD | -2761.37% |
| 2014 Q4 | -1.05 Million AUD | 0.0% |
| 2014 Q3 | -1.05 Million AUD | 0.0% |
| 2013 FY | 279.94 Thousand AUD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| EZZ Life Science Holdings Limited | -18.89 Million AUD | 94.803% |
| Zelira Therapeutics Limited | 5.06 Million AUD | 119.381% |
| Biome Australia Limited | -1.56 Million AUD | 37.157% |
| Patrys Limited | -2.24 Million AUD | 56.169% |
| Orthocell Limited | -19.92 Million AUD | 95.071% |
| Imugene Limited | -91.56 Million AUD | 98.927% |
| Noxopharm Limited | -2.31 Million AUD | 57.666% |
| PYC Therapeutics Limited | -65.76 Million AUD | 98.507% |
| Chimeric Therapeutics Limited | -3.05 Million AUD | 67.831% |
| Prescient Therapeutics Limited | -10.16 Million AUD | 90.336% |
| Proteomics International Laboratories Limited | -6.32 Million AUD | 84.47% |
| Cynata Therapeutics Limited | -6.2 Million AUD | 84.173% |
| CSL Limited | 15.76 Billion AUD | 100.006% |
| Arovella Therapeutics Limited | -12.71 Million AUD | 92.276% |
| Bio-Gene Technology Limited | -709.55 Thousand AUD | -38.411% |
| Clinuvel Pharmaceuticals Limited | -182.98 Million AUD | 99.463% |
| Starpharma Holdings Limited | -19.83 Million AUD | 95.048% |
| Nanollose Limited | -96.22 Thousand AUD | -920.636% |
| Memphasys Limited | 4.13 Million AUD | 123.749% |
| Invex Therapeutics Ltd | -6.02 Million AUD | 83.7% |
| NeuroScientific Biopharmaceuticals Limited | -4.95 Million AUD | 80.176% |
| Amplia Therapeutics Limited | -1.82 Million AUD | 46.144% |
| Botanix Pharmaceuticals Limited | -79.3 Million AUD | 98.762% |
| Island Pharmaceuticals Limited | -1.23 Million AUD | 20.696% |
| Race Oncology Limited | -17.18 Million AUD | 94.286% |
| Nyrada Inc. | -4.76 Million AUD | 79.408% |
| Telix Pharmaceuticals Limited | -105.79 Million AUD | 99.072% |
| Dimerix Limited | -21.99 Million AUD | 95.534% |
| PharmAust Limited | -9.71 Million AUD | 89.89% |
| Immutep Limited | -122.18 Million AUD | 99.196% |
| Clarity Pharmaceuticals Ltd | -136.5 Million AUD | 99.281% |
| Alterity Therapeutics Limited | -12.47 Million AUD | 92.13% |
| BTC Health Limited | -2.02 Million AUD | 51.433% |
| Acrux Limited | -1.45 Million AUD | 32.64% |
| Neuren Pharmaceuticals Limited | -17.09 Million AUD | 94.255% |
| Biotron Limited | -386.06 Thousand AUD | -154.387% |
| Tissue Repair Ltd | -16.44 Million AUD | 94.026% |
| AdAlta Limited | -845.17 Thousand AUD | -16.202% |
| Radiopharm Theranostics Limited | -18.57 Million AUD | 94.713% |
| Hexima Limited | -2.22 Million AUD | 55.884% |
| AnteoTech Limited | -5 Million AUD | 80.364% |
| Paradigm Biopharmaceuticals Limited | -17.58 Million AUD | 94.414% |
| Recce Pharmaceuticals Ltd | -3.39 Million AUD | 71.082% |
| Avecho Biotechnology Limited | -5.32 Million AUD | 81.571% |
| Actinogen Medical Limited | -9.13 Million AUD | 89.245% |
| Immuron Limited | -11.48 Million AUD | 91.448% |
| Argenica Therapeutics Limited | -15.91 Million AUD | 93.828% |